Search Results - "Vanhaudenarde, Vincent"
-
1
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)
Published in BMC cancer (02-12-2021)“…Cisplatin-based neoadjuvant chemotherapy (NAC) followed by surgery is the standard treatment for patients with non-metastatic muscle invasive bladder cancer…”
Get full text
Journal Article Web Resource -
2
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors
Published in Nature medicine (01-12-2023)Get full text
Journal Article -
3
Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer: AURA (Oncodistinct-004) trial
Published in Journal of clinical oncology (01-06-2022)“…4517 Background: Nearly half of the patients (pts) diagnosed with non-metastatic muscle invasive bladder cancer are unfit for cisplatin therapy and no…”
Get full text
Journal Article -
4
BrainStorm: A brain metastases research platform to tackle the challenge of central nervous system (CNS) metastases in solid tumors (Oncodistinct 006)
Published in Journal of clinical oncology (20-05-2021)“…Abstract only TPS2066 Background: Better knowledge on the evolving epidemiology and biology of CNS metastases are key elements for the development of new…”
Get full text
Journal Article -
5
Abstract CT202: CSFctDNA as a surrogate for tumor tissue DNA in BC pts with CNS metastases: First results from the Brainstorm program (Oncodistinct 006)
Published in Cancer research (Chicago, Ill.) (05-04-2024)“…Background: Central nervous system (CNS) metastases display molecular alterations that differ from primary tumors and metastatic sites, which might confer…”
Get full text
Journal Article